The quarter is winding down, and here are some highlights from this past week's earnings coverage from BloggingStocks:

• Air Products & Chemicals Inc. (NYSE: APD) lowered its guidance for the current quarter.
• AutoZone Inc. (NYSE: AZO) missed Q4 earnings estimates despite a modest increase in profits.
• Bed Bath & Beyond Inc. (NASDAQ: BBBY) reported disappointing Q2 results that met analysts' expectations.
• Chevron Corp. (NYSE: CVX) faces earnings declines if the Paulson plan fails, says Jim Cramer
• Circuit City Stores Inc. (NYSE: CC) earnings declines finally led to the ouster of CEO Schoonover.
• Discover Financial Services (NYSE: DFS) beat Q3 expectations despite charges and reserves.
• General Electric Co. (NYSE: GE) lowered its Q3 and full-year forecast due to financial sector woes.
• KB Home (NYSE: KBH) reported a greater-than-expected loss for Q3, and yet shares rose.
• Lennar Corp. (NYSE: LEN) posted significantly smaller Q3 losses on cost cutting.
• McCormick & Co. Inc. (NYSE: MKC) topped Q3 expectations due to the sale of a brand.
• Nike Inc. (NYSE: NKE) posted better-than-expected Q1 results despite a decline in net income.
• Research in Motion Ltd. (NASDAQ: RIMM) posted strong Q2 results accompanied by a weak forecast.
• Rite Aid Corp. (NYSE: RAD) Q2 net loss more than doubled and revenues were flat
• Secure Computing Corp. (NASDAQ: SCUR) missing estimates didn't stop a deal with McAfee (NYSE: MFE).
• 3Com Corp. (NASDAQ: COMS) Q1 results topped both analysts estimates and previous guidance.
• 3M Co. (NYSE: MMM) faces significant earnings declines if the Paulson plan fails, says Jim Cramer.

Also, are analysts' expectations for the the coming year too optimistic?

Upcoming quarterly reports include Circuit City (NYSE: CC), Walgreen (NYSE: WAG), Pepsi Bottling Group (NYSE: PBG), Constellation Brands (NYSE: STZ), Marriott International (NYSE: MAR), Family Dollar Stores (NYSE: FDO).

Visit AOL Money & Finance for more earnings coverage.

Ever read an earnings report and say to yourself, "man, there's just nothing going on here?" I did exactly that Wednesday with Bed Bath & Beyond (NASDAQ: BBBY) and its second-quarter report.

To be fair, something is going on with the retailer. Earnings per diluted share decreased 16% to 46 cents. And net cash from operating activities took a big 40% dive, coming in at $168 million. So, yes, something is going on, it just isn't anything good.

And if you think those stats are bad, consider that same-store sales for the quarter went down by 0.1%. Okay, is it really fair to point out that comps declined by 0.1%? Shouldn't I have just said "flat" instead? I mean, it's almost like rubbing the depressing results in the face of management by literally writing the exact percentage that comps declined at when said percentage is so unequivocally small. Hey, maybe management needs a reminder that, in the year-ago quarter, comps were actually up to the tune of 2.2%. What happened?

Well, I will cut some slack here since we are in the grips of an economic mess and I certainly would assume that all the problems in the housing industry are taking their noxious toll on the retailer. I'm not sure consumers are in the mood to buy a lot of bathroom accessories while Congress is trying to figure out how to keep the financial matrix from imploding.

Earnings reports continue to dribble in as the quarter winds down. Much of the attention this week will be on homebuilders KB Home (NYSE: KBH) and Lennar Corp. (NYSE: LEN) as investors look for any sign that the housing sector has bottomed (home sales numbers are also due out this week; see below). Analysts surveyed by Thomson Financial anticipate that both companies will report that they narrowed their losses in the most recent quarter.

KB Home's expected $1.25 per share loss, on revenue of $725.5 million, compares to the previous quarter loss of $3.30 and to a year-ago loss of $6.19. However, KB Home's losses in the past few quarters have been deeper than expected. The Los Angeles-based homebuilder's long-range earnings growth forecast is 10.5%, less than the S&P 500. Analysts continue to recommend holding KB Home, and have for at least 120 days. Shares, however, reached a new 52-week high of $31.69 on Friday, and they are up 10.5% year to date.

Lennar is expected to post a loss of 52 cents per share, on revenue of $1.1 billion. That compares to the previous quarter's per-share loss of 76 cents and to a year-ago loss of $3.25. While Lennar also has tended in the past few quarters to miss expectations, the Miami-based company managed a positive surprise in the first quarter of 2008. Lennar's long-range earnings growth forecast is 10.3%, about the same as KB Home's. Analysts also recommend holding Lennar. Friday, shares of Lennar also reached a 52-week high, $27.75, but they are down 6.4% year to date.

Here are some highlights from this past week's earnings coverage from BloggingStocks:

• Bed Bath & Beyond Inc. (NASDAQ: BBBY) Q1 earnings tumbled while revenues rose.
• Casella Waste Systems Inc. (NASDAQ: CWST) posted a narrower-than-expected Q4 loss.
• CKE Restaurants Inc. (NYSE: CKR) Q1 earnings increased but its revenue slipped.
• Darden Restaurants Inc. (NYSE: DRI) swung to a Q4 profit on strong sales at Olive Garden.
• Ericsson (NASDAQ: ERIC) said it might not see Q2 profit growth on lower demand and shipping delays.
• General Mills Inc. (NYSE: GIS) Q4 earnings declined but were in line with expectations.
• Gerber Scientific Inc. (NYSE: GRB) reported solid Q4 and full-year results that pleased investors.
• IHS Inc. (NYSE: IHS) beat Q2 expectations and posted record quarterly cash flow from operations.
• Jabil Circuit Inc. (NYSE: JBL) stronger-than-expected Q3 results led to an analyst's upgrade.
• KB Home (NYSE: KBH) widened its Q2 loss due to weak sales and falling prices.
• Kroger Co. (NYSE: KR) beat Q1 expectations as consumers sought discounts on food and gas.
• Monsanto Co. (NYSE: MON) beat Q3 earnings estimates but fell short of revenue estimates.
• Nike Inc. (NYSE: NKE) posted better-than-expected Q4 results boosted by international strength.
• Oracle Corp. (NASDAQ: ORCL) posted strong Q4 results that topped analysts' expectations (see transcript).

Here's a quick recap of some additional earnings reports on Wednesday.

Beaverton, Ore.-based Nike Inc. (NYSE: NKE) said strong growth overseas helped boost its fourth-quarter profit by 12% to $490.5 million, or 98 cents per share. Analysts polled by Thomson Financial expected the company to earn 96 cents per share for the quarter. Shares fell more than 5% in after-hours trading to $62.15.

CKE Restaurants Inc. (NYSE: CKR) said its first-quarter profit climbed 8% to $16.6 million, or 31 cents per share, helped by a small increase in same-store sales at Carl's Jr. restaurants. Revenue fell 3% to $466.2 million. Analysts polled by Thomson Financial expected profit of 27 cents per share on revenue of $465.5 million. Shares fell 5 cents to $12.25 in after-hours trading.

Red Hat Inc. (NYSE: RHT) said its fiscal first-quarter profit rose 6.6% to $17.3 million, or 8 cents per share. Adjusted earnings were 18 cents per share. Revenue rose 32% to $156.6 million. Analysts polled by Thomson Financial on average predicted a profit of 18 cents per share on revenue of $153 million. Shares fell 19 cents in after-hours trading to $22.11.

General Mills Inc. (NYSE: GIS) said its fourth-quarter profit dropped 17% to $185.2 million, or 53 cents per share. Adjusted earnings were 73 cents per share, which met Wall Street expectations. Sales increased 13% to $3.47 billion beating expectations. The company reaffirmed its guidance for the full year. Shares fell almost 2% to $61.19.

Here are a few highlights of this past week's earnings coverage from BloggingStocks:

• Alcoa Inc. (NYSE: AA) will kick off the new earnings season next week, but expectations are low.
• Bed Bath & Beyond Inc. (NASDAQ: BBBY) met low earnings estimates but shares dropped to a new low.
• Cal-Maine Foods' (NYSE: CALM) revenue and profit soared on strength in the market for fresh eggs.
• Merge Technologies Inc. (NASDAQ: MRGE) announced another dismal quarter, along with an SEC probe.
• Monsanto Co. (NYSE: MON) beat earnings expectations and revised its guidance.
• Retalix Ltd. (NASDAQ: RTLX) warned that it would miss earnings estimates again this quarter.

Also, Jim Cramer thinks that downgrades of tech stocks don't make sense in light of their strong fourth quarter, but analysts seem to be pessimistic in general about earnings forecasts. Ted Allrich thinks this is the wrong time to ignore financial stocks, despite recent losses.

Upcoming results to watch for include Alcoa Inc. (NYSE: AA) and KB Home (NYSE: KBH).

Visit AOL Money & Finance for more earnings coverage.

MOST NOTEWORTHY: NYSE Group Inc (NYX), Patterson-UTI Energy (PTEN) and HomeBanc Corp (HMB) were today's more notable downgrades:

• JP Morgan downgraded shares of the NYSE Group Inc (NYSE: NYX) to Underweight from Neural to reflect their belief that the company's float will increase significantly in March due to the acquisition of Euronext and the lockup expiration. JP Morgan believes this could bring selling pressure.
  

• Credit Suisse downgraded shares of Patterson-UTI Energy (NASDAQ: PTEN) citing negative earnings impact from share losses and industry capacity additions.

• Shares of HomeBanc Corp (NYSE: HMB) were downgraded to Underperform from Market Perform with a $2.60 target at Friedman Billings based on continued losses and an unlikely sale given market conditions.

OTHER DOWNGRADES:

• Wachovia downgraded Hub International Ltd (NYSE: HBG) to Market Perform from Outperform following news of a private-equity acquisition for $40 a share.

• UBS downgraded Bed Bath & Beyond Inc (NASDAQ: BBBY) to Neutral from Buy on valuation.

• Citigroup downgraded Burlington Northern Santa Fe Corp (NYSE: BNI) to Hold from Buy.

• AG Edwards cut Teekay LNG Partners (NYSE: TGP) and Teekay Offshore Partners (NYSE: TOO) to Hold from Buy citing valuation.

• Raymond James downgraded shares of Marvel Entertainment Inc (NYSE: MVL) to Market Perform from Outperform.

• Lazard downgraded Thoratec Corp (NASDAQ: THOR) to Sell from Hold with a $15 target. They recommend selling shares ahead of a likely FDA decision to call an advisory panel for HeartMate II.

Analyst summaries provided by TheFlyOnTheWall.com (subscription required).